| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9527 |
| Human Intestinal Absorption | HIA+ | 0.9843 |
| Caco-2 Permeability | Caco2+ | 0.6926 |
| P-glycoprotein Substrate | Substrate | 0.5000 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7047 |
| Non-inhibitor | 0.8273 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8926 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8398 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8431 |
| CYP450 2D6 Substrate | Non-substrate | 0.8743 |
| CYP450 3A4 Substrate | Non-substrate | 0.6294 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5578 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7196 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8833 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7031 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8191 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6080 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9678 |
| Non-inhibitor | 0.8558 |
| AMES Toxicity | Non AMES toxic | 0.8476 |
| Carcinogens | Non-carcinogens | 0.5604 |
| Fish Toxicity | High FHMT | 0.9929 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9882 |
| Honey Bee Toxicity | High HBT | 0.6081 |
| Biodegradation | Ready biodegradable | 0.5575 |
| Acute Oral Toxicity | IV | 0.5907 |
| Carcinogenicity (Three-class) | Warning | 0.4755 |